Can ultrasound be as a surrogate marker for diagnosing a papillary thyroid cancer? Comparison with BRAF mutation analysis

Jae Young Seo, Eun Kyung Kim, Jung Hwan Baek, Jung Hee Shin, Kyung Hwa Han, Jin Young Kwak

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: We investigated the merit of ultrasound (US) features and BRAFV600E mutation as an additional study of cytology and compared the diagnostic performances of cytology alone, cytology with US correlation, cytology with BRAFV600E mutation, and a combination of cytology, US, and BRAFV600E mutation all together. Materials and Methods: This study included 185 patients (mean age, 48.4 years; range 20--77 years) with 191 thyroid nodules who underwent US-guided fine-needle aspiration (FNA) with an additional BRAFV600E mutation test. Three radiologists highly experienced in thyroid imaging retrospectively reviewed US images and classified each nodule into two categories (positive for malignancy or negative for malignancy). Interobserver variability (IOV) of US assessment between the three readers was estimated using the generalized kappa statistic of Landis and Koch. We also calculated the diagnostic performances of these studies. Results: There were 131 cases of malignancy (131/191, 68.6%) and 60 cases of benign nodules (60/191, 31.4%). In terms of IOV of US assessment, the generalized kappa value was 0.242, indicating fair agreement was reached. The combination of cytology with BRAFV600E showed higher specificity (100%) and positive predictive value (PPV) (100%) compared to the combination of cytology, BRAFV600E, and US (specificity 28.3%, 66.7%, 68.3%; PPV 74.6%, 86.6%, 86.8%, respectively; p<0.001). However, cytology with BRAFV600E showed lower sensitivity (84.7%) than cytology with BRAFV600E and US (96.2%, 98.5%, 95.4%, respectively; p<0.001). Conclusion: Considering the diagnostic performance and low reproducibility of US, the combination of FNA with BRAFV600E is the most reliable and objective method for diagnosing thyroid malignancy.

Original languageEnglish
Pages (from-to)871-878
Number of pages8
JournalYonsei medical journal
Volume55
Issue number4
DOIs
Publication statusPublished - 2014 Jul

Fingerprint

Cell Biology
Biomarkers
Mutation
Observer Variation
Fine Needle Biopsy
Neoplasms
Thyroid Gland
Papillary Thyroid cancer
Thyroid Nodule

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{9855d7cd9e514762921544a1dd25819f,
title = "Can ultrasound be as a surrogate marker for diagnosing a papillary thyroid cancer? Comparison with BRAF mutation analysis",
abstract = "Purpose: We investigated the merit of ultrasound (US) features and BRAFV600E mutation as an additional study of cytology and compared the diagnostic performances of cytology alone, cytology with US correlation, cytology with BRAFV600E mutation, and a combination of cytology, US, and BRAFV600E mutation all together. Materials and Methods: This study included 185 patients (mean age, 48.4 years; range 20--77 years) with 191 thyroid nodules who underwent US-guided fine-needle aspiration (FNA) with an additional BRAFV600E mutation test. Three radiologists highly experienced in thyroid imaging retrospectively reviewed US images and classified each nodule into two categories (positive for malignancy or negative for malignancy). Interobserver variability (IOV) of US assessment between the three readers was estimated using the generalized kappa statistic of Landis and Koch. We also calculated the diagnostic performances of these studies. Results: There were 131 cases of malignancy (131/191, 68.6{\%}) and 60 cases of benign nodules (60/191, 31.4{\%}). In terms of IOV of US assessment, the generalized kappa value was 0.242, indicating fair agreement was reached. The combination of cytology with BRAFV600E showed higher specificity (100{\%}) and positive predictive value (PPV) (100{\%}) compared to the combination of cytology, BRAFV600E, and US (specificity 28.3{\%}, 66.7{\%}, 68.3{\%}; PPV 74.6{\%}, 86.6{\%}, 86.8{\%}, respectively; p<0.001). However, cytology with BRAFV600E showed lower sensitivity (84.7{\%}) than cytology with BRAFV600E and US (96.2{\%}, 98.5{\%}, 95.4{\%}, respectively; p<0.001). Conclusion: Considering the diagnostic performance and low reproducibility of US, the combination of FNA with BRAFV600E is the most reliable and objective method for diagnosing thyroid malignancy.",
author = "Seo, {Jae Young} and Kim, {Eun Kyung} and Baek, {Jung Hwan} and Shin, {Jung Hee} and Han, {Kyung Hwa} and Kwak, {Jin Young}",
year = "2014",
month = "7",
doi = "10.3349/ymj.2014.55.4.871",
language = "English",
volume = "55",
pages = "871--878",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "4",

}

Can ultrasound be as a surrogate marker for diagnosing a papillary thyroid cancer? Comparison with BRAF mutation analysis. / Seo, Jae Young; Kim, Eun Kyung; Baek, Jung Hwan; Shin, Jung Hee; Han, Kyung Hwa; Kwak, Jin Young.

In: Yonsei medical journal, Vol. 55, No. 4, 07.2014, p. 871-878.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Can ultrasound be as a surrogate marker for diagnosing a papillary thyroid cancer? Comparison with BRAF mutation analysis

AU - Seo, Jae Young

AU - Kim, Eun Kyung

AU - Baek, Jung Hwan

AU - Shin, Jung Hee

AU - Han, Kyung Hwa

AU - Kwak, Jin Young

PY - 2014/7

Y1 - 2014/7

N2 - Purpose: We investigated the merit of ultrasound (US) features and BRAFV600E mutation as an additional study of cytology and compared the diagnostic performances of cytology alone, cytology with US correlation, cytology with BRAFV600E mutation, and a combination of cytology, US, and BRAFV600E mutation all together. Materials and Methods: This study included 185 patients (mean age, 48.4 years; range 20--77 years) with 191 thyroid nodules who underwent US-guided fine-needle aspiration (FNA) with an additional BRAFV600E mutation test. Three radiologists highly experienced in thyroid imaging retrospectively reviewed US images and classified each nodule into two categories (positive for malignancy or negative for malignancy). Interobserver variability (IOV) of US assessment between the three readers was estimated using the generalized kappa statistic of Landis and Koch. We also calculated the diagnostic performances of these studies. Results: There were 131 cases of malignancy (131/191, 68.6%) and 60 cases of benign nodules (60/191, 31.4%). In terms of IOV of US assessment, the generalized kappa value was 0.242, indicating fair agreement was reached. The combination of cytology with BRAFV600E showed higher specificity (100%) and positive predictive value (PPV) (100%) compared to the combination of cytology, BRAFV600E, and US (specificity 28.3%, 66.7%, 68.3%; PPV 74.6%, 86.6%, 86.8%, respectively; p<0.001). However, cytology with BRAFV600E showed lower sensitivity (84.7%) than cytology with BRAFV600E and US (96.2%, 98.5%, 95.4%, respectively; p<0.001). Conclusion: Considering the diagnostic performance and low reproducibility of US, the combination of FNA with BRAFV600E is the most reliable and objective method for diagnosing thyroid malignancy.

AB - Purpose: We investigated the merit of ultrasound (US) features and BRAFV600E mutation as an additional study of cytology and compared the diagnostic performances of cytology alone, cytology with US correlation, cytology with BRAFV600E mutation, and a combination of cytology, US, and BRAFV600E mutation all together. Materials and Methods: This study included 185 patients (mean age, 48.4 years; range 20--77 years) with 191 thyroid nodules who underwent US-guided fine-needle aspiration (FNA) with an additional BRAFV600E mutation test. Three radiologists highly experienced in thyroid imaging retrospectively reviewed US images and classified each nodule into two categories (positive for malignancy or negative for malignancy). Interobserver variability (IOV) of US assessment between the three readers was estimated using the generalized kappa statistic of Landis and Koch. We also calculated the diagnostic performances of these studies. Results: There were 131 cases of malignancy (131/191, 68.6%) and 60 cases of benign nodules (60/191, 31.4%). In terms of IOV of US assessment, the generalized kappa value was 0.242, indicating fair agreement was reached. The combination of cytology with BRAFV600E showed higher specificity (100%) and positive predictive value (PPV) (100%) compared to the combination of cytology, BRAFV600E, and US (specificity 28.3%, 66.7%, 68.3%; PPV 74.6%, 86.6%, 86.8%, respectively; p<0.001). However, cytology with BRAFV600E showed lower sensitivity (84.7%) than cytology with BRAFV600E and US (96.2%, 98.5%, 95.4%, respectively; p<0.001). Conclusion: Considering the diagnostic performance and low reproducibility of US, the combination of FNA with BRAFV600E is the most reliable and objective method for diagnosing thyroid malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84903126049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903126049&partnerID=8YFLogxK

U2 - 10.3349/ymj.2014.55.4.871

DO - 10.3349/ymj.2014.55.4.871

M3 - Article

C2 - 24954313

AN - SCOPUS:84903126049

VL - 55

SP - 871

EP - 878

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 4

ER -